Evidence map›Paper›PMID 37865409›Full record

Observational studyBMJ open2023

Changing trends of the diseases burden attributable to high BMI in Asia from 1990 to 2019: results from the global burden of disease study 2019.

Xue Li, Fang Han, Na Liu, Xiaojin Feng, Xiaodong Sun, Yuhua Chi, Ningning Hou, Yongping Liu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xue Li *Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Fang Han *Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang, China.
Na Liu *Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Xiaojin FengDepartment of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Xiaodong SunDepartment of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Yuhua ChiDepartment of General Medicine, Affiliated Hospital of Weifang Medical University, Weifang, China.
Ningning HouDepartment of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.
Yongping LiuDepartment of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China lypfree@hotmail.com.ORCID 0000-0002-6466-483X
Weifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyse the trends of diseases burden attributed to high body mass index (BMI), including overweight and obesity, in Asia from 1990 to 2019.

designObservational study.

settingThe data of 45 countries and regions in Asia were obtained from the Global Burden of Disease Study 2019 database.

main outcome measuresNumbers, age-standardised rate (ASR) of deaths and disability-adjusted life years (DALYs), and the corresponding estimated annual percentage changes (EAPCs), attributable to high BMI in Asia from 1990 to 2019, were analysed by regions, genders and age. We also analysed changes in the causes of deaths and DALYs that are attributable to high BMI over this period.

resultsIn 2019, all causes deaths attributable to high BMI in Asia were 2 329 503, with increases by 265% compared with 1990. Over three decades, DALYs related to high BMI have increased by 268%. The ASRs of deaths and DALYs in Asia both showed continuous upward trends during this period (EAPC 1.39; 95% certainty interval [95% CI] 1.35 to 1.43 for deaths; EAPC 1.8; 95% CI 1.76 to 1.84 for DALYs), while both were declined in high-income areas (EAPC -2.03 and -1.26). By geographical regions, disease burden in Central Asia and West Asia have been fluctuating at high levels, but high-income Asia Pacific showed decreasing trends of ASR of deaths (EAPC -2.03) and DALYs (EAPC -1.26). Over this period, disease burden in Asia was changing from women to men, and tends to ageing. In addition, diabetes were the diseases most affected by high BMI, and cancer burden was high in middle-aged and elderly people.

conclusionsThe disease burden attributed to high BMI in Asia has experienced great changes. It is necessary to promote the prevention of obesity and chronic diseases in a comprehensive manner, especially in low-income areas, men and elderly.

Indexed as

Global Burden of DiseaseObesityAgedAsiaBody Mass IndexFemaleGlobal HealthHumansMaleMiddle AgedQuality-Adjusted Life YearsRisk Factorsepidemiologyobesitypublic health

Identifiers

PMID37865409
PMCPMC10603495
OpenAlexW4387849996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.